08/30/2024
3:47 PM | Bhatia Sangeeta N. (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/30/2024
3:23 PM | LEIDEN JEFFREY M (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/12/2024
3:08 PM | Bhatia Sangeeta N. (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
10:47 AM | Bhatia Sangeeta N. (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024
8:52 AM | Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/01/2024
3:17 PM | Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2024
2:34 PM | SACHS BRUCE I (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
07/30/2024
2:25 PM | Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/25/2024
3:06 PM | Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2024
3:05 PM | Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2024
11:27 AM | Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/22/2024
12:16 PM | Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024
9:27 AM | Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/26/2024
9:23 AM | Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/13/2024
3:09 PM | Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
3:11 PM | Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2024
8:54 AM | Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/12/2024
8:56 AM | Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2024
3:11 PM | Vertex Pharmaceuticals (Issuer)
WAGNER CHARLES F JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
3:09 PM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
12:56 PM | Vertex Pharmaceuticals (Subject)
WAGNER CHARLES F JR (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024
12:38 PM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/31/2024
9:50 AM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/30/2024
10:48 AM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/29/2024
3:08 PM | Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
9:05 AM | Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/28/2024
9:51 AM | Vertex Pharmaceuticals (Subject)
WAGNER CHARLES F JR (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/24/2024
12:13 PM | Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/22/2024
3:21 PM | Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
12:45 PM | SACHS BRUCE I (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/20/2024
2:32 PM | Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/20/2024
7:36 AM | Vertex Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/20/2024
7:25 AM | ALPINE IMMUNE SCIENCES, INC. (Subject)
Vertex Pharmaceuticals (Filed by)
| Form SC TO-T/A | |
05/15/2024
11:20 AM | Sachdev Amit (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/15/2024
10:41 AM | ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/15/2024
10:50 AM | Arbuckle Stuart A (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/10/2024
7:01 AM | ALPINE IMMUNE SCIENCES, INC. (Subject)
Vertex Pharmaceuticals (Filed by)
| Form SC TO-T/A | |
05/08/2024
7:54 AM | ALPINE IMMUNE SCIENCES, INC. (Subject)
Vertex Pharmaceuticals (Filed by)
| Form SC TO-T/A | |
05/03/2024
3:05 PM | Bhatia Sangeeta N. (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
9:07 AM | Bhatia Sangeeta N. (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/22/2024
3:15 PM | ALPINE IMMUNE SCIENCES, INC. (Subject)
Vertex Pharmaceuticals (Filed by)
| Form SC TO-T | |
Pre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳 (Ad) 45M Users | 32,481% Growth Rate
Get in on the biggest disruption to smartphones in over a decade. Reg A investment now open. Claim Exclusive 100% Bonus: $0.25/Share |
04/16/2024
3:56 PM | Arjuna Capital (Filed by)
Vertex Pharmaceuticals (Subject)
| Form PX14A6G | |
04/11/2024
3:08 PM | ALPINE IMMUNE SCIENCES, INC. (Subject)
Vertex Pharmaceuticals (Filed by)
| Form SC TO-C | |
04/11/2024
6:13 AM | Vertex Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2024
6:17 AM | Vertex Pharmaceuticals (Subject)
| Form SC TO-C | |
04/10/2024
4:22 PM | ALPINE IMMUNE SCIENCES, INC. (Subject)
Vertex Pharmaceuticals (Filed by)
| Form SC TO-C | |
04/10/2024
11:14 AM | Capital World Investors (Filed by)
Vertex Pharmaceuticals (Subject)
| Form SC 13G/A | |
04/04/2024
3:05 PM | Vertex Pharmaceuticals (Filer)
| Form ARS | |
02/27/2024
3:44 PM | Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
3:37 PM | Arbuckle Stuart A (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
3:24 PM | ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2024
12:19 PM | Arbuckle Stuart A (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024
10:25 AM | ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024
10:10 AM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024
9:44 AM | Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024
9:52 AM | Sachdev Amit (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2024
9:26 AM | Sanna Bastiano (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/23/2024
3:28 PM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
3:16 PM | Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
3:43 PM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
3:49 PM | Vertex Pharmaceuticals (Issuer)
WAGNER CHARLES F JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
3:38 PM | Sachdev Amit (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
3:26 PM | Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
3:29 PM | Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
10:38 AM | Arbuckle Stuart A (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024
9:44 AM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024
9:52 AM | Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024
9:16 AM | ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024
8:50 AM | Sanna Bastiano (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024
8:43 AM | Sachdev Amit (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024
10:03 AM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024
10:29 AM | Arbuckle Stuart A (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024
9:57 AM | ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024
9:32 AM | Sanna Bastiano (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024
9:22 AM | Sachdev Amit (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2024
9:22 AM | Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/15/2024
10:19 AM | LEIDEN JEFFREY M (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024
4:11 PM | Sanna Bastiano (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/13/2024
4:34 PM | Vertex Pharmaceuticals (Issuer)
WAGNER CHARLES F JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
4:23 PM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
12:42 PM | Biller Jonathan (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024
12:24 PM | Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024
11:44 AM | Arbuckle Stuart A (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024
10:32 AM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024
9:32 AM | ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/12/2024
8:52 AM | Sachdev Amit (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/09/2024
5:19 PM | Capital World Investors (Filed by)
Vertex Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/09/2024
9:05 AM | FMR LLC (Filed by)
Vertex Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/08/2024
3:38 PM | Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
3:40 PM | LEIDEN JEFFREY M (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
3:43 PM | Sachdev Amit (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Pre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳 (Ad) 45M Users | 32,481% Growth Rate
Get in on the biggest disruption to smartphones in over a decade. Reg A investment now open. Claim Exclusive 100% Bonus: $0.25/Share |
02/08/2024
3:45 PM | Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
3:47 PM | Vertex Pharmaceuticals (Issuer)
WAGNER CHARLES F JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
3:20 PM | Ambrose Kristen (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
3:10 PM | ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
3:09 PM | Vertex Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2024
3:06 PM | LEIDEN JEFFREY M (Reporting)
Vertex Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
3:56 PM | LEIDEN JEFFREY M (Reporting)
Vertex Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/04/2024
3:17 PM | Vertex Pharmaceuticals (Issuer)
WAGNER CHARLES F JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/02/2024
9:32 AM | Vertex Pharmaceuticals (Subject)
WAGNER CHARLES F JR (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Free VRTX Stock Alerts